Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
145.7 USD | -0.23% |
|
-0.08% | -7.05% |
03/07 | Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer | MT |
03/07 | Johnson & Johnson Lung Cancer Drug Gets Health Canada Approval | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
1st Jan change | Capi. | |
---|---|---|
-7.05% | 35TCr | |
+54.07% | 81TCr | |
+38.95% | 62TCr | |
+15.44% | 32TCr | |
+5.72% | 29TCr | |
+14.21% | 24TCr | |
-0.45% | 22TCr | |
+14.58% | 22TCr | |
+7.42% | 17TCr | |
-3.79% | 16TCr |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Transcript : Johnson & Johnson Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-12-2015 10